Tokyo, Dec. 29 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060223) titled 'Investigation of gastric cancer treatment using zolbetuximab' on Dec. 28.
Study Type:
Observational
Primary Sponsor:
Institute - Yamagata Prefectural Shinjo Hospital
Condition:
Condition - Gastric cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - Evaluation of factors associated with the therapeutic effect of zolbetuximab
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients with gastric cancer who have received chemotherapy
Key exclusion criteria - Patients judged ineligible for the study by the investigator
Target Size - 50
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2025 Year 11 Month 10 Day
Date of IRB - 2025 Year 12 Month 09 Day
Anticipated trial start date - 2025 Year 12 Month 09 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068885
Disclaimer: Curated by HT Syndication.
